AbbVie Inc. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (14 lists). Names and jurisdictions are as filed.
- 2025-02-14: Subsidiary AbbVie Finance Corporation Delaware.
- 2025-02-14: Subsidiary AbbVie Respiratory LLC Delaware.
- 2025-02-14: Subsidiary AGN Labs LLC Delaware.
- 2025-02-14: Subsidiary Allergan Laboratories, LLC Delaware.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2025-02-14 | AbbVie Finance Corporation Delaware | |
| 2025-02-14 | AbbVie Respiratory LLC Delaware | |
| 2025-02-14 | AGN Labs LLC Delaware | |
| 2025-02-14 | Allergan Laboratories, LLC Delaware | |
| 2025-02-14 | Anterios, Inc. Delaware | |
| 2025-02-14 | Cerevel MA Securities Corp. Massachusetts | |
| 2025-02-14 | Exemplar Pharma, LLC Delaware | |
| 2025-02-14 | Knoll Pharmaceutical Company New Jersey | |
| 2025-02-14 | Neptunite, LLC Delaware | |
| 2025-02-14 | Silicone Engineering, Inc. California | |
| 2025-02-14 | Vitae Pharmaceuticals, LLC Delaware | |
| 2025-02-14 | AbbVie Pty Ltd Australia | |
| 2025-02-14 | AbbVie Global Enterprises Ltd. Bermuda | |
| 2025-02-14 | Warner Chilcott Holdings Company III, Limited Bermuda | |
| 2025-02-14 | AbbVie Productos Farmacéuticos Limitada Chile | |
| 2025-02-14 | AbbVie s.r.o. Czech Republic | |
| 2025-02-14 | AbbVie Deutschland GmbH & Co. KG Germany | |
| 2025-02-14 | AbbVie Healthcare India Private Limited India | |
| 2025-02-14 | Allergan Unlimited Company Ireland | |
| 2025-02-14 | Warner Chilcott Intermediate (Ireland) Unlimited | |
| 2025-02-14 | Allergan NK Japan | |
| 2025-02-14 | Allergan Holdings S.à r.l. Luxembourg | |
| 2025-02-14 | AbbVie B.V. Netherlands | |
| 2025-02-14 | AbbVie Venezuela Holdings B.V. Netherlands | |
| 2025-02-14 | Knoll LLC Puerto Rico | |
| 2025-02-14 | AbbVie s.r.o. Slovakia | |
| 2025-02-14 | Allergan Pharmaceuticals Taiwan Co. Ltd. Taiwan | |
| 2025-02-14 | AbbVie Trustee Company Limited United Kingdom |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |